Search

Investors
Australia offers a wealth
of opportunities

utility-emailutility-printutility-pdfContact usChange to standard fontChange to large font

Investor Update: BiotechnologyClick to subscribe to this Investor Updates RSS feed

Investment syndicate boosts Australian biotech commercialisation
11 Aug 2011
A new consortium of local and foreign investors will enable an Australian biotech venture, Vaxxas, to commercialise its unique product.
New bionic hearing aid developed in Australia
18 May 2011
Researchers based in Melbourne, Australia have invented a smart, self-managed hearing aid using bionic ear technology.
Australia continues to be an attractive destination for FDI
6 May 2011
Foreign direct investment (FDI) into Australia continues to grow, demonstrating investor confidence in the strong Australian economy. Data released by the Australian Bureau of Statistics* shows that, year on year, FDI into Australia grew by 7.5 per c ...
Cutting-edge cancer centre to open in Australia
17 Dec 2010
German company Fresenius Kabi will open a $3.5 million oncology compounding centre in Brisbane, in the New Year.
Construction begins on Australia’s first Translational Research Institute
3 Dec 2010
Construction has begun on Australia’s first Translational Research Institute (TRI): a facility dedicated to translating scientific discoveries into applications for medical practice.
Australia pilots world’s first solar powered dialysis unit
8 Nov 2010
The German health care company, Fresenius Medical Care and Barwon Health, Victoria, have piloted the world’s first solar powered dialysis unit at Geelong Hospital.
Australian scientists make important finding in critical auto-immune disease
3 Nov 2010
Australian scientists at Sydney’s Garvan Institute of Medical Research have made an important finding about Type 1 diabetes.
Spanish biopharmaceutical group expands in Australia
20 Oct 2010
The Spanish biopharmaceutical group of companies, Grifols SA, has invested an expansion of its diagnostic plant in Melbourne, Australia.
Japanese pharma in deal with Australian biotech
8 Oct 2010
The Japanese pharmaceutical company, Daiichi Sankyo, has received approval in Japan to manufacture and market a new treatment for influenza developed by the ASX-listed Australian biotech, Biota Holdings.
Australian scientists make significant HIV discovery
1 Oct 2010
Australian scientists have made a significant discovery in the battle against HIV, which could lead to a possible cure.

Site Information

Austrade makes no warranty, express or implied as to the fitness for a particular purpose, or assumes any legal liability for the accuracy or usefulness of any information contained in this document. Any consequential loss or damage suffered as a result of reliance on this information is the sole responsibility of the user.